8-K: Sabra Health Care REIT Reports Solid Q1 2024 Results, Reaffirms Full-Year Guidance

Sentiment:

Quarterly Report


Sabra Health Care REIT announced its first quarter 2024 results, showing improvements in key portfolio metrics and reiterating its full-year 2024 guidance.

Summary

  • Sabra Health Care REIT reported a net income of $0.11 per diluted share for the first quarter of 2024.
  • The company's Funds From Operations (FFO) was $0.32 per diluted share, with Normalized FFO at $0.34 per diluted share.
  • Adjusted Funds From Operations (AFFO) and Normalized AFFO both came in at $0.35 per diluted share.
  • EBITDARM coverage for skilled nursing facilities was 1.79x, and for senior housing leased properties, it was 1.33x.
  • The company declared a quarterly cash dividend of $0.30 per share, payable on May 31, 2024.
  • Sabra is maintaining its 2024 earnings guidance, with net income projected between $0.53 and $0.57 per diluted share.
  • The company's 2024 FFO guidance is between $1.33 and $1.37 per diluted share, and Normalized FFO is projected to be between $1.34 and $1.38 per diluted share.
  • AFFO is expected to be between $1.38 and $1.42 per diluted share, and Normalized AFFO is projected to be between $1.39 and $1.43 per diluted share.
  • These projections assume no acquisitions or dispositions in 2024.
  • As of March 31, 2024, Sabra had approximately $913.8 million in liquidity, including $59.9 million in unrestricted cash and $853.9 million available under its revolving credit facility.
  • The company also has $500 million available under its ATM program.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with solid Q1 results and reaffirmed guidance. While there are some negative aspects, the overall tone is optimistic and indicates a stable financial position.

Positives

  • The portfolio continues to grow stronger with improvements in coverage, occupancy, and NOI.
  • Trailing-twelve-month SNF coverage saw a healthy 0.06x increase sequentially, to 1.79x, when excluding the impact of Provider Relief Funds.
  • The SHOP portfolio continues to improve, and this quarter's results are in line with expectations.
  • The balance sheet remains strong and is poised to support future growth.
  • The pipeline for new investments has improved, with expectations to announce new investments on the second quarter call.

Negatives

  • The company had a net loss on sales of real estate of $21.5 million.
  • There was a loss on extinguishment of debt of $1.541 million.
  • The company had an impairment of real estate of $3.137 million.

Risks

  • Increased labor costs and historically low unemployment could impact operations.
  • Increases in market interest rates and inflation could affect financial performance.
  • Pandemics or epidemics, including COVID-19, could impact tenants and communities.
  • Operational risks with respect to Senior Housing Managed communities could pose challenges.
  • Competitive conditions in the industry could affect profitability.
  • The loss of key management personnel could impact the company.
  • Uninsured or underinsured losses affecting properties could lead to financial strain.
  • Potential impairment charges and adjustments related to the accounting of assets could occur.
  • The variability of reported rental and related revenues due to accounting standards could impact results.
  • Risks associated with investments in unconsolidated joint ventures could affect performance.
  • Catastrophic weather and other natural or man-made disasters could impact properties.
  • Increased operating costs and competition for tenants could affect profitability.
  • Increased healthcare regulation and enforcement could pose challenges.
  • Tenants' dependency on reimbursement from governmental and third-party payor programs could create risks.
  • The effect of tenants declaring bankruptcy or becoming insolvent could impact revenue.
  • The ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties could pose challenges.
  • The impact of litigation and rising insurance costs on the business of tenants could affect performance.
  • The impact of required regulatory approvals of transfers of healthcare properties could cause delays.
  • Environmental compliance costs and liabilities associated with real estate properties could create financial strain.
  • Tenants' failure to adhere to privacy and data security laws could lead to breaches.
  • The company's concentration in the healthcare property sector makes it vulnerable to downturns in specific sectors.
  • The significant amount of indebtedness and the ability to service it could pose challenges.
  • Covenants in debt agreements may restrict the ability to pay dividends, make investments, incur additional debt, and refinance debt.
  • Adverse changes in credit ratings could impact the company.
  • The ability to make dividend distributions at expected levels could be affected.
  • The ability to raise capital through equity and debt financings could be impacted.
  • Changes and uncertainty in macroeconomic conditions and disruptions in financial markets could affect performance.
  • Risks associated with ownership of property outside the U.S., including currency fluctuations, could impact results.
  • The relatively illiquid nature of real estate investments could pose challenges.
  • The ability to maintain REIT status under federal tax laws could be affected.
  • Compliance with REIT requirements and certain tax matters could pose challenges.
  • Changes in tax laws and regulations affecting REITs could impact performance.
  • Ownership limits and takeover defenses in governing documents may restrict change of control opportunities.
  • Exclusive forum provisions in bylaws could impact legal proceedings.

Future Outlook

Sabra is reiterating its 2024 earnings guidance, assuming no acquisitions or dispositions, with net income projected between $0.53 and $0.57 per diluted share, FFO between $1.33 and $1.37 per diluted share, Normalized FFO between $1.34 and $1.38 per diluted share, AFFO between $1.38 and $1.42 per diluted share, and Normalized AFFO between $1.39 and $1.43 per diluted share.

Management Comments

  • Rick Matros, CEO and Chair, stated that Sabra's portfolio continues to grow stronger, whether looking at coverage, occupancy, or NOI.
  • Rick Matros also mentioned that the balance sheet remains strong and is poised to support future growth.
  • Rick Matros noted that the pipeline has improved and they expect to announce new investments on the second quarter call.
  • Talya Nevo-Hacohen, Chief Investment Officer, stated that by consistently and deliberately executing their strategy, they deliver long-term value to shareholders and provide the capital their tenants need to invest in their business and deliver quality care.

Industry Context

The results reflect a continued recovery in the healthcare real estate sector, with improvements in key metrics like occupancy and EBITDARM coverage. The company's focus on skilled nursing and senior housing aligns with the growing demand for these services due to an aging population. The reiteration of 2024 guidance suggests confidence in the company's ability to navigate the current economic environment.

Comparison to Industry Standards

  • Sabra's Net Debt to Adjusted EBITDA of 5.55x is within the range of its investment-grade peers, which range from 4.37x to 6.86x.
  • Sabra's Interest Coverage Ratio of 4.06x is also within the range of its investment-grade peers, which range from 3.80x to 4.82x.
  • Sabra's Debt as a % of Asset Value of 37% is within the range of its investment-grade peers, which range from 26% to 48%.
  • Sabra's Secured Debt as a % of Asset Value of 1% is also within the range of its investment-grade peers, which range from 0% to 9%.
  • Compared to peers like OHI, AHR, LTC, NHI and CTRE, Sabra has a lower forward FFO multiple, suggesting a potentially undervalued stock.
  • Sabra's dividend yield is competitive with its peers.
  • Sabra's portfolio composition shows a higher concentration in skilled nursing compared to some peers, but a lower concentration in senior housing compared to others.
  • Sabra's SNF EBITDARM coverage of 1.79x is within the range of its peers, while its SH EBITDARM coverage of 1.33x is also within the range of its peers.

Stakeholder Impact

  • Shareholders will benefit from the declared dividend and the company's strong financial position.
  • Employees will benefit from the company's commitment to diversity, equity, and inclusion.
  • Tenants will benefit from the company's support and investment in their success.
  • Customers will benefit from the company's focus on quality care and its partnerships with skilled operators.
  • Creditors will benefit from the company's strong balance sheet and prudent financial management.

Next Steps

  • The company intends to present the materials attached to the report in investor presentations.
  • The company expects to announce new investments on the second quarter call.

Key Dates

DateDescription
March 31, 2024End of the first quarter for which financial results are reported.
May 8, 2024Date of the earnings release and declaration of the quarterly dividend.
May 9, 2024Date of the conference call to discuss the first quarter results.
May 20, 2024Record date for the quarterly cash dividend.
May 31, 2024Payment date for the quarterly cash dividend.

Keywords

REIT, Healthcare, Skilled Nursing, Senior Housing, EBITDARM, FFO, AFFO, Real Estate, Investments, Dividends

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.